TLM Debrief 2: Basic Science, Hepatitis, HCC, Cholestatic, MASLD, Alcohol-Associated Liver Disease and MetALD Debrief

Description

The debrief sessions summarize the highest impact papers addressing key topics across the field of hepatology presented during The Liver Meeting. A group of original research reports reflecting major advances in hepatology are succinctly reviewed. Debrief 2 will address basic science research, hepatitis, hepatocellular carcinoma, cholestatic liver disease, alcohol-associated liver disease and MetALD, and metabolic dysfunction-associated liver disease.

Presentations

8:00 AM - 8:30 AM
Nov 11 2025
San Diego, CA

Basic Science Debrief

Carmen Wong, PhD, Presenter
ALD
Basic Science
Hepatitis
Liver Cancer
MASLD
8:30 AM - 9:00 AM
Nov 11 2025
San Diego, CA

Hepatitis Debrief

Mindie H. Nguyen, MD, MAS, AGAF, FAASLD, Presenter
ALD
Basic Science
Hepatitis
Liver Cancer
MASLD
9:00 AM - 9:30 AM
Nov 11 2025
San Diego, CA

Hepatocellular Carcinoma Debrief

Lauren D Nephew, MD, MSCE, Presenter
ALD
Basic Science
Hepatitis
Liver Cancer
MASLD
9:30 AM - 10:00 AM
Nov 11 2025
San Diego, CA

Cholestatic Liver Disease Debrief

Cynthia Levy, MD, FAASLD, Presenter
ALD
Basic Science
Hepatitis
Liver Cancer
MASLD
10:00 AM - 10:30 AM
Nov 11 2025
San Diego, CA

Alcohol-Associated Liver Disease and MetALD Debrief

Brian P Lee, MD, Presenter
ALD
Basic Science
Hepatitis
Liver Cancer
MASLD
10:30 AM - 11:00 AM
Nov 11 2025
San Diego, CA

MASLD Debrief

Mohammad S Siddiqui, MD, Presenter
ALD
Basic Science
Hepatitis
Liver Cancer
MASLD

Objectives

  • Analyze new discoveries in hepatology and their relationship to the existing knowledge base in the field.